M. Castro

Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.

E. Spitznagel, R. Slavin, C. Bellone, 2000, The Journal of allergy and clinical immunology.

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?

M. Gaboli, O. Neth, P. Olbrich, 2021, Journal of Clinical Immunology.